In an exchange filing, Fortis said: "The company is currently evaluating the judgement and exploring legal means to address it in an expeditious manner, keeping in mind the best interest of all our stakeholders.
"Separately, we have been advised that the open offer made by IHH Healthcare Berhad ('IHH') to the public shareholders of Fortis for the acquisition of shareholding of up to 26 per cent at a price of Rs 170 per share continues to remain in abeyance and would be adjudicated upon in conjunction with the hearing of the contempt petition," it said.
The company's response comes after last week's Supreme Court ruling in which it held Fortis' former promoters Malvinder Singh and Shivinder Singh guilty of contempt and asked them to deposit Rs 1,175 crore each.
The court had sought an enquiry into finalisation of the acquisition of healthcare assets from the Religare Health Trust (RHT) Health Trust by the company.
"The company remains firm that these transactions were, at all times, conducted in a fair and transparent manner after obtaining all relevant regulatory, shareholder and corporate approvals and only after making all due disclosures to public shareholders of the Company and to the regulatory authorities, in a timely manner," Fortis said.
The court's order came in response to Japanese pharma firm Daiichi Sankyo's petition to implement the Rs 3,500 crore arbitration award against Singh brothers, who they allege to have concealed information related to the extent of regulatory problems at Ranbaxy.
IHH, via Northern TK Venture Pte, had last November completed the purchase of 31.1 per cent stake in Fortis for Rs 4,000 crore.
( With inputs from IANS )